Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients (STOP-NT)

This study has been terminated.
(Independent biostatistician recommended early termination of the trial due to low probability of success.)
Sponsor:
Information provided by (Responsible Party):
Jose Vazquez, Henry Ford Health System
ClinicalTrials.gov Identifier:
NCT01734694
First received: November 14, 2012
Last updated: July 8, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)